
Marjorie Rah, OD, PhD, FAAO, discussed the in-home use test of BioTrue Hydration Plus multipurpose contact lens solution (Bausch + Lomb) on patients who are considering lens dropout.

Marjorie Rah, OD, PhD, FAAO, discussed the in-home use test of BioTrue Hydration Plus multipurpose contact lens solution (Bausch + Lomb) on patients who are considering lens dropout.

Selina McGee, OD, FAAO, shares an overview of a panel on Thyroid Eye Disease that took place at Controversies in Modern Eye Care.

Melissa Tawa, OD, FAAO, chats about glaucoma case studies, surgical interventions, and appropriate technology choices based on patients at the 18th Annual Controversies in Modern Eye Care meeting.

Mary Beth Yackey, OD, and Michael Javaheri, MD, share their perspectives on the modernization of geographic atrophy identification and treatment.

Marc Bloomenstein, OD, FAAO, discusses how optometrists can proactively manage Demodex blepharitis by regularly examining eyelids, diagnosing the condition early, and offering treatments to effectively eradicate the mites and prevent future complications.

Catch up on what happened in optometry during the week of April 29-May 3.

The AI-powered eye diagnostic innovator and medical devices and software solutions company have announced a collaboration to promote an AI diagnostic tool that assesses risk to brain health via retinal imaging.

The Diffusion Optics Technology, or DOT 0.2, works by utilizing thousands of light scattering elements to mimic natural contrast on the retina, which can slow myopia progression in child, according to the company.

The almost 474,000 participants in the study had been diagnosed with uveitis between January 1, 2015, and February 25, 2021 in South Korea.

The technology works by concentrating a specific band of light, typically 650 nm, into a laser beam to irradiate the retina.

The diagnostic screening technology is able to diagnose diabetic retinopathy by using 1 image taken of each eye with over 99% imageability.

The non-randomized, open label, safety and efficacy study will inject a sustained release implant in 5 participants.

The company's ONE by ONE and Biotrue Eye Care Recycling programs have collected over 84 million units or over 500,000 pounds, of used contact lenses, eye care and lens care materials in the US.

Joseph Izatt, PhD, was known for his excellence in mentorship and his work as a researcher that helped develop and advance optical coherence tomography technology, according to a news release.

Association of Schools and Colleges of Optometry President Mark Colip, OD, overviews the organization’s recent faculty report and details a new mentorship program for potential optometry students.

Effective management of turnover can have a big impact on revenue.

Catch up on what happened in optometry during the week of April 22-April 26.

The nutritional supplement comprised of a proprietary blend of lutein, zeaxanthin isomers, curcumin, and vitamin D3 improved tear production, tear film break-up time, and tear osmolarity, among others.

UC Berkeley’s Herbert Wertheim School of Optometry and Vision Science integrated the new laser in the beginning of March in its dry eye clinic for treatment of meibomian gland dysfunction.

Michele Andrews, OD, vice president of professional and government affairs for CooperVision, and Terri A. Gossard, OD, MS, member of the AOA board of trustees, sat down with Optometry Times to discuss the goals and tactics of The Myopia Collective.

Community Eye Care Specialists has a total of 6 locations across New York and Pennsylvania providing a variety of medical and surgical services.

The new technology, tailored to creative professionals, reduces the light that passes through the lens without reducing the color of light that is transmitted.

The IOL launch is the company’s second market debut in less than 12 months.

The World Council of Optometry partners with key optometric organizations for 2025 conference and appoints expert leaders in myopia management for education and outreach.

The WVU Health System Board of Directors recently approved $233.5 million to fund the construction of a multi-center outpatient facility with additional exam and testing rooms.

OCU410 utilizes an AAV delivery platform for the retinal delivery of the RORA gene, the company stated in a news release.

The AI-powered model works to detect early signs of glaucoma and makes iHealthScreen the first company to receive 2 US patents for AMD and glaucoma screening devices.

Evaluating and managing lid margin disease and meibomian gland dysfunction.

Catch up on what happened in optometry during the week of April 15-April 19.

The goal of the grant funding from the Choroideremia Research Foundation is to support validation of functional vision assessments for patients with profound blindness.